BRAF and cancer: Mutations in the kinase domain of BRAF, specifically found at the V600 site, are frequently found to be drivers of cancer, including a prevalence of mutations noted in, but not exclusive to, melanoma, colorectal cancer, non‐small cell lung cancer and differentiated thyroid cancer.1, 2, 3, 4, 5